I. Fleury and E. Laverdure, “Bispecific Antibodies and Chimeric Antigen Receptor (CAR) T-cell Therapy for Indolent Lymphoma”, Can Hematol Today, vol. 2, no. 3, pp. 5–11, Nov. 2023.